Thrilled to announce the June winner of our #ResearchIsBeautiful image campaign: Michaela Macdonald from Carcinotech Ltd Michaela’s image captures a 3D-bioprinted living tumour derived from donor glioblastoma tissue. Carcinotech specialises in crafting these bioengineered tumours from patient biopsies, offering researchers and drug developers an alternative to animal models for screening and testing cancer therapies. Interested in taking part? Drop us an email by 25th of each month with your wonderful moments of science to win our monthly pick. T&Cs apply. https://lnkd.in/efB-ujNF
Cancer Research UK Science and Innovation’s Post
More Relevant Posts
-
Director of Clinical Research Operations @ the University of Pennsylvania- Abramson Cancer Center Clinical Research Unit
Progress, Potential, and Possibilities Podcast with Dr. Susan Domchek Susan Domchek, MD, director of the Basser Center for BRCA at Penn Medicine, discussed her path to breast cancer genetics research and how the Basser Center is working to improve care and future outcomes for people with a family history of cancer, including carriers of BRCA gene mutations, which increase an individual’s risk of developing certain cancers. https://lnkd.in/e5YTpchW
Dr. Susan Domchek, MD - Executive Director, Basser Center for BRCA, Abramson Cancer Center, Penn
https://www.youtube.com/
-
Sales and Marketing at MatTek IVLSL | In Vitro Tissue models 🧫 | Non-animal testing assays 🐇
This webinar should be very interesting, as there is a high demand for the BBB models... I am curious...
📺 Join us for a new webinar: Unlocking Breakthroughs in Glioblastoma Research, Thursday, October 26th at 9AM ET. Are you passionate about advancing cancer research and exploring innovative therapies for Glioblastoma (GBM)? We invite you to an informative webinar focusing on the pivotal role of the blood-brain barrier (BBB) in tumorigenesis and therapy resistance. Join presenter Maxine Lam, PhD, for a case study exploring the groundbreaking potential of disease modeling in vitro. Register Now: https://lnkd.in/gzBMyHX6
-
Join us for this upcoming webinar in conjunction with MatTek Life Sciences. Dr. Maxine Lam from Singapore's A*STAR - Agency for Science, Technology and Research, Institute of Molecular and Cell Biology, will discuss practical implementation of a functional in vitro human Blood Brain Barrier and Glioblastoma model to investigate mechanisms of drug resistance in vascularized glioblastoma tumor spheroids using AIM Biotech's organiX platform. Check out the post below to register! #pharmacology #neuroscience #oncology #drugdevelopment #drugdiscovery
📺 Join us for a new webinar: Unlocking Breakthroughs in Glioblastoma Research, Thursday, October 26th at 9AM ET. Are you passionate about advancing cancer research and exploring innovative therapies for Glioblastoma (GBM)? We invite you to an informative webinar focusing on the pivotal role of the blood-brain barrier (BBB) in tumorigenesis and therapy resistance. Join presenter Maxine Lam, PhD, for a case study exploring the groundbreaking potential of disease modeling in vitro. Register Now: https://lnkd.in/gzBMyHX6
-
Bringing value from R&D to production | Accelerating your projects based on genetic analysis | Covering France, Germany, Austria, Switzerland and Africa
On-Demand Webinar: Combination Therapies Driving the Need for Expanded Genotyping Information. https://buff.ly/3rNf378 Learn about the role of genotypic biomarkers in understanding cancer biology and predicting therapeutic success. Don't miss out on speakers who delve into understanding underlying cancer pathophysiology and optimizing fragment analysis¬based MSI testing in FFPE.
On-Demand Webinar
thermofisher.com
-
Precision Medicine Entrepreneur | CEO of Adela. Founder of Genome Medical and Clarified Precision Medicine. Board Member, Advisor, Speaker, Global Educator. Twitter: @LisaA
New approaches to liquid biopsy are being discussed at #PMWC to impact patient care over the cancer care continuum. Daniel De Carvalho, PhD from Adela, Inc. shares the importance of measuring cell-free methylated DNA to understand the changes in cancer biology for dynamic patient monitoring. This will help us better determine how to treat the patient. #precisionmedicine #liquidbiopsy
-
-
Bioscience Account Manager- Thermo Fisher Scientific. We support your research from bench to beside.
Did you know that up to 80% of cancer diagnoses occur at the metastatic stage? Monitoring cancer therapy at this advanced stage can be challenging. Join Dr. Pravin D. Potdar as he shares insights into methods for circulating tumor cell (CTC) enumeration and isolation, as well as the importance of molecular profiling for diagnosing and monitoring metastatic cancers. Register for this on-demand webinar to stay informed about the latest advancements in cancer research!
Methods for circulating tumor cell (CTC) enumeration and isolation
thermofisher.com
-
Biosciences Account Manager at Thermo Fisher Scientific- Serving the University of Michigan
Did you know that up to 80% of cancer diagnoses occur at the metastatic stage? Monitoring cancer therapy at this advanced stage can be challenging. Join Dr. Pravin D. Potdar as he shares insights into methods for circulating tumor cell (CTC) enumeration and isolation, as well as the importance of molecular profiling for diagnosing and monitoring metastatic cancers. Register for this on-demand webinar to stay informed about the latest advancements in cancer research!
Methods for circulating tumor cell (CTC) enumeration and isolation
thermofisher.com
-
Exciting news! BioTechniques interviewed our experts on the latest breakthroughs in tumor organoids. Get an inside look at the advantages of these 3D models over traditional 2D cell cultures, as well as the best practices for establishing organoids from patient samples and optimal culture conditions. Are you curious about how these 3D models are advancing cancer research? Read the full interview on BioTechniques: https://hubs.li/Q02zNWZb0
-
-
Meet Alexander (Lex) Eggermont MD, PhD, Chief Scientific Officer at our coordinating partner Prinses Máxima Centrum voor kinderoncologie, and a driving force behind the Organoids platform within Oncode Accelerator. His vision? "Immuno-competent organoids with a stromal compartment—a perfect in vitro model to study tumors." Organoids, mini organs grown from specific cell types, are revolutionizing cancer research. According to Alexander, these models hold immense potential in drug development, offering an alternative to animal testing. He believes they are a key feature in the paradigm shift in cancer treatment. Read the whole interview 👉 https://lnkd.in/eCjcdWAg #cancerResearch #organoids
-
-
Embrace the future of cancer research and discover liquid biopsy with RGCC International! Our tests are accurate at identifying circulating tumor cells in patients' blood. They provide a comprehensive genomic profile of advanced cancer - without the need for invasive procedures. Find more info in our article here: https://lnkd.in/dnJ98mda #cancertesting #liquidbiopsy
-
*Currently on Maternity Leave*
2wAmazing Michaela! 👏